Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCR4-NOT transcription complex subunit 4 (CNOT4) is a protein component of the highly conserved, multifunctional CCR4-NOT complex, which acts as a major regulator of mRNA metabolism and gene expression in eukaryotic cells[1][2][3]. The CCR4-NOT complex is involved in various aspects of mRNA processing and decay, specifically catalyzing deadenylation (the shortening of poly(A) tails), thereby marking mRNA for degradation and regulating translation[1][2][3]. CNOT4, as part of this multiprotein complex, also participates in transcriptional regulation, protein ubiquitination, chromatin modification, and cellular quality control mechanisms[1][2][3]. Disruption of CCR4-NOT complex function, including that of CNOT4, can impact cell cycle regulation, DNA repair, and may be associated with diseases such as cancer and neurodegenerative disorders[3]. CNOT4 is not considered a direct therapeutic target or receptor but is essential for cellular homeostasis due to its role in post-transcriptional and transcriptional regulation[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CCR4-NOT transcription complex subunit 4 (CNOT4).